prikaz prve stranice dokumenta Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage
  Preuzmi
PDF 134.85 KB
Znanstveni rad - Izvorni znanstveni rad
Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage
Anticancer Research, 40 (2020), 4; 2323-2329. https://doi.org/10.21873/anticanres.14199
Ovčariček, Petra Petranović; Fröbe, Ana; Verburg, Frederik Anton; Murgić, Jure; Butković, Marija Bosak; Ovčariček, Slaven; Mažuran, Berislav; Krušlin, Božo; Jakovčević, Danica; Šoipi, Šoip; Ružić, Boris; Milošević, Milan; Krilić, Dražena; Franceschi, Maja; Jukić, Tomislav Više autora...

Institucijski repozitorij: Repozitorij stomatološkog fakulteta u Zagrebu

Citirajte ovaj rad

Ovčariček, P. P., Fröbe, A., Verburg, F. A., Murgić, J., Butković, M. B., Ovčariček, S. ... Jukić, T. (2020). Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage. Anticancer Research, 40. (4), 2323-2329. doi: 10.21873/anticanres.14199

Ovčariček, Petra Petranović, et al. "Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage." Anticancer Research, vol. 40, br. 4, 2020, str. 2323-2329. https://doi.org/10.21873/anticanres.14199

Ovčariček, Petra Petranović, Ana Fröbe, Frederik Anton Verburg, Jure Murgić, Marija Bosak Butković, Slaven Ovčariček, Berislav Mažuran, et al. "Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage." Anticancer Research 40, br. 4 (2020): 2323-2329. https://doi.org/10.21873/anticanres.14199

Ovčariček, P. P., et al. (2020) 'Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage', Anticancer Research, 40(4), str. 2323-2329. doi: 10.21873/anticanres.14199

Ovčariček PP, Fröbe A, Verburg FA, Murgić J, Butković MB, Ovčariček S, i sur.. Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage. Anticancer Research [Internet]. 31.03.2020. [pristupljeno 27.12.2024.];40(4):2323-2329. doi: 10.21873/anticanres.14199

P. P. Ovčariček, et al., "Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage", Anticancer Research, vol. 40, br. 4, str. 2323-2329, Ožujak 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:127:784774. [Citirano: 27.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:127:784774
Podaci o radu
Naslov (engleski)Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage
AutorPetra Petranović Ovčariček
AutorAna Fröbe
AutorFrederik Anton Verburg
AutorJure Murgić
AutorMarija Bosak Butković
AutorSlaven Ovčariček
AutorBerislav Mažuran
AutorBožo Krušlin
AutorDanica Jakovčević
AutorŠoip Šoipi
AutorBoris Ružić
AutorMilan Milošević
AutorDražena Krilić
AutorMaja Franceschi
AutorTomislav Jukić
Autorova ustanovaZdravstveno veleučilište
Autorova ustanova(Klinička bolnica Sv. Duh)
Autorova ustanova(Klinički bolnički centar Sestre milosrdnice)
Autorova ustanovaSveučilište u Zagrebu
Stomatološki fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
Background/Aim: The aim of this study was to determine the association between total triiodothyronine (T3), free fraction of thyroxin (FT4), and thyrotropin (TSH) levels with prostate cancer histopathological features. Patients and Methods: Blood samples from 140 patients with prostate cancer were analyzed preoperatively and stratified according to postoperative histopathological differentiation. The first group (N=62) included patients with prostate cancer Grade Groups (GG) 1-2, while the second group (N=63) included patients with prostate cancer GG 3-5. Results: T3 levels were significantly higher in patients with prostate cancer GG 3-5 (p=0.047). There was no significant difference in the FT4 and TSH levels between the two groups (p=0.680 and 0.801, respectively). T3 levels were positively correlated with tumor percentage involvement (TPI) (p=0.002), and pT stage (p=0.047) on definitive pathology. Conclusion: Higher T3 levels are associated with several indicators of prostate cancer histopathological aggressiveness.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaAnticancer Research
Brojčani podacivol. 40, br. 4, str. 2323-2329
p-ISSN0250-7005
e-ISSN1791-7530
DOIhttps://doi.org/10.21873/anticanres.14199
URN:NBNurn:nbn:hr:127:784774
Datum objave publikacije2020-03-31
URL dokumentahttp://ar.iiarjournals.org/lookup/doi/10.21873/anticanres.14199
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-10-23 10:46:01